Isothermal amplification and CRISPR reporter assays can generate large amounts of nucleic acid or highly responsive cleavage signals. A false-positive pattern may originate from prior amplicon carryover, contaminated raw materials, fresh nonspecific amplification, sample cross-contamination, reporter nuclease contamination, or data interpretation. These mechanisms require different controls and corrective actions.
Contamination control should be designed into the facility, workflow, reagent chemistry, device, and quality system. It cannot be added only after no-template controls begin to fail.
| Failure class | Typical source | Pattern | Corrective direction |
|---|---|---|---|
| Amplicon carryover | Prior LAMP, RPA, PCR, or transcription product | Intermittent clusters, spatial or temporal association, product identity matches prior assay | Workflow separation, closed tubes, decontamination, dUTP/UDG where compatible |
| Reagent contamination | Enzyme, water, oligonucleotide, buffer, consumable, or manufacturing environment | Blank failures follow a component or lot | Component substitution, incoming controls, process investigation |
| De novo nonspecific amplification | Primer-primer reaction, unintended template, trigger leakage | Reproducible late NTC signal without prior-product pattern | Primer/probe redesign, enzyme ratio, activation, temperature, read-time limit |
| Sample cross-contamination | Splash, aerosol, shared tool, leaking container, batch handling | High-positive adjacency or operator/run association | Collection and handling redesign, barriers, single-use tools, run layout |
| Reporter background | DNase/RNase, unprogrammed Cas activity, optical or strip artifact | Signal without correct amplicon or activator | Reporter-only controls, nuclease QC, guide-minus tests, readout investigation |
Pre-amplification reagent preparation, sample addition, amplification, and post-amplification analysis should move in one direction. Dedicated tools, protective clothing, consumables, and storage reduce reverse transfer. The degree of physical separation should follow risk; high-yield LAMP products and open lateral-flow transfer create a particularly strong amplicon source.
Operational controls may include:
Physical workflow controls also protect against sample-to-sample contamination and reagent contamination, which chemical carryover systems may not address.
Fluorescent and many colorimetric assays can be read without opening the vessel. Integrated cartridges can move amplification product into a detection zone while remaining sealed. For lateral flow, closed cassettes, pierceable internal reservoirs, or compartment-release mechanisms can avoid manual tube opening.
If opening is unavoidable, the process should occur in a controlled post-amplification area. The device and instructions should minimize aerosol generation, and amplified waste should not return to the reagent-preparation space.
Replacing part or all of dTTP with dUTP labels new amplicons with uracil. Before a subsequent reaction, uracil-DNA glycosylase can damage uracil-containing carryover so it no longer amplifies efficiently. Thermolabile UDG can be inactivated during the reaction temperature, depending on the enzyme and protocol.
This strategy requires demonstration that the amplification polymerase accepts dUTP, analytical sensitivity and kinetics remain acceptable, UDG does not damage the current reaction after activation, and the treatment degrades a realistic contaminant load. It does not remove non-uracil legacy amplicons, genomic DNA contamination, RNA contamination, sample cross-contamination, or freshly generated nonspecific products.
The multiple primers can form extendable structures that generate late no-template amplification. Primer-subset experiments, alternative primer families, loop-primer removal, temperature and ratio changes, and product identity analysis help distinguish this route from carryover. A shorter valid read window can exclude late background only if low-level positives remain reliably detectable.
Low-temperature activity can begin during setup. Primer or probe interactions, magnesium activation, uneven mixing, and multi-protein balance may produce background. Setup-hold studies and staged activation help determine whether false signal begins before incubation.
Cas reporter cleavage may be triggered by an unintended amplicon, primer-derived activator, contaminating nucleic acid, or unprogrammed nuclease. Guide-minus, enzyme-minus, amplification-minus, synthetic activator, and reporter-only controls separate these routes. Cas13 workflows need strong RNase control; Cas12 workflows need control of ssDNase contamination.
Polymerases, reverse transcriptases, Cas enzymes, carrier proteins, and other biologically produced components may contain residual host nucleic acids or nuclease activities. Oligonucleotides can carry synthesis or handling contaminants. Water and common buffers can become contaminated during repeated access.
Incoming and release testing should be risk based. Blank reactions, target-specific qPCR or sequencing where justified, residual nuclease assays, and component-combination controls can identify problematic lots. Testing the complete master mix is important because individually undetectable backgrounds may become amplifiable together.
| Control | Where it enters | What it monitors |
|---|---|---|
| Reagent blank | Before any sample contact | Master-mix and setup environment |
| Matrix blank | Through sample preparation | Collection, preparation, and matrix-associated signal |
| Extraction/process control | Before preparation | Recovery, inhibition, and workflow integrity |
| NTC | At amplification setup | Amplification background and setup contamination |
| Transfer blank | During post-amplification step | Open transfer or device contamination |
| Environmental blank | Risk-based location or time | Persistent workspace or equipment contamination |
Controls should be distributed through a run when spatial patterns matter. A single NTC at one plate corner cannot detect every dispensing or adjacency effect.
First preserve records, reaction curves, plate maps, lot numbers, operator information, and environmental conditions. Do not immediately clean every area and discard all materials before collecting evidence. Repeat selected blanks with fresh aliquots in a controlled clean area, substitute one component at a time, and compare product identity with prior amplicons.
Spatial clustering suggests splash, aerosol, or dispensing patterns. Lot-wide blank failure suggests a component. Consistent late NTC kinetics with multiple fresh lots suggests primer or reaction background. Cas signal without amplifiable product suggests reporter or nuclease issues. Corrective action should follow the supported route.
Chemical and ultraviolet methods have material- and sequence-dependent effectiveness. UV exposure may not reach shaded surfaces and can damage equipment or reagents. Cleaning agents require correct concentration, contact time, surface compatibility, and removal where residues could inhibit assays.
Decontamination is complete only when verification criteria are met. Reagent blanks, environmental samples where used, and multiple subsequent clean runs provide stronger evidence than one negative NTC.
Bulk enzyme, oligonucleotide, master-mix, dispense, and packaging areas need defined material and personnel flow. Positive-control material and amplified product should be isolated from clean manufacturing. Batch records should trace raw-material lots, open times, equipment, cleaning, environmental excursions, and deviations.
Dry reagents require special care because contamination can be distributed across many units before detection. Representative within-lot sampling and negative-control testing should reflect dispense position and manufacturing sequence.
Negative-control results should be trended by date, room, operator, instrument, reagent lot, primer set, product family, and plate or device position. An increasing frequency of late signals can indicate gradual workspace burden, reagent drift, or a narrowing reaction window before outright failures occur. Time-to-signal distributions often contain more information than binary pass/fail calls.
Alert limits should distinguish isolated stochastic events from recurring patterns, while still requiring investigation of any result that could compromise a run. A laboratory should not widen the negative threshold repeatedly to keep aging reagents or a contaminated workflow in specification.
A corrective action addresses the demonstrated cause; a preventive action reduces recurrence elsewhere. If carryover entered during open strip transfer, cleaning alone is temporary—the workflow or device should be redesigned. If one oligonucleotide lot contains target sequence, supplier and incoming controls need review. If late NTCs are de novo, room decontamination will not replace primer redesign.
A complete investigation record should include:
